Levetiracetam
Product Images NDC 14335-050

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 14335-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hainan Poly Pharm. Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (01)

This is a table showing the percentage of patients on placebo and two different doses of Levetiracetam (1,000 mg/day and 3,000 mg/day). The number of patients in each group is also provided.*

FDA Label Image

Figure 2 (02)

FDA Label Image

Figure 3 (03)

This is a table showing the percentage of patients in two groups: Placebo (N=104) and Levetiracetam 3,000 mg/day (N=180). The percentages range from 0% to 45% in increments of 5%.*

FDA Label Image

Figure 4 (04)

The text represents a graph showing the percentage of patients who participated in a study and received either a placebo or Levetiracetam. The data is presented in a bar graph format with the percentages on the y-axis and the two groups on the x-axis. The placebo group had a percentage of 19.6% while the Levetiracetam group had a percentage of 44.6%.*

FDA Label Image

Figure 5 (05)

FDA Label Image

Figure 6 (06)

This appears to be a table showing the percentage of patients who received either a placebo or levetiracetam in a medical study. The percentage of patients who received levetiracetam is not provided, but the percentage of patients who received the placebo is 45.2%. The number of patients in the placebo group is 84, and the number of patients in the levetiracetam group is 79.*

FDA Label Image

Principal Display Panel (100 mg/mL Vial Carton)

This is a description of a medication called Levetiracetam Injection USP. It is available in a package containing 10 single-dose vials that are 5 mL each, with a strength of 500 mg/5 mL (100 mg/mL). This medication is for intravenous use and must be diluted before administration. It is only available with a prescription and is sterile. The usual dosage and other important information are not available. The medication is made by a company with the NDC number 14335-050-10, and the package contains a lot number and an expiration date.*

FDA Label Image

Chemical Structure (Levetiracetam 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.